BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28501115)

  • 1. Postconditioning attenuates coronary perivascular and interstitial fibrosis through modulating angiotensin II receptors and angiotensin-converting enzyme 2 after myocardial infarction.
    Wang ZF; Wang NP; Harmouche S; Philip T; Pang XF; Bai F; Zhao ZQ
    J Surg Res; 2017 May; 211():178-190. PubMed ID: 28501115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of inflammatory response and reduction in infarct size by postconditioning are associated with downregulation of early growth response 1 during reperfusion in rat heart.
    Wang NP; Pang XF; Zhang LH; Tootle S; Harmouche S; Zhao ZQ
    Shock; 2014 Apr; 41(4):346-54. PubMed ID: 24365880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
    Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
    Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.
    Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ
    Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats.
    Wang ZF; Wang NP; Harmouche S; Philip T; Pang XF; Bai F; Zhao ZQ
    Basic Res Cardiol; 2013 Jan; 108(1):318. PubMed ID: 23203208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans.
    Fan Q; Yang XC; Liu Y; Wang LF; Liu SH; Ge YG; Chen ML; Wang W; Zhang LK; Irwin MG; Xia Z
    Clin Sci (Lond); 2011 Mar; 120(6):251-61. PubMed ID: 20919993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent beneficial effect of postconditioning against infarct size: role of mitochondrial K(ATP) channels during reperfusion.
    Mykytenko J; Reeves JG; Kin H; Wang NP; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2008 Sep; 103(5):472-84. PubMed ID: 18600365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil inhibition contributes to cardioprotection by postconditioning.
    Granfeldt A; Jiang R; Wang NP; Mykytenko J; Eldaif S; Deneve J; Zhao ZQ; Guyton RA; Tønnesen E; Vinten-Johansen J
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):48-56. PubMed ID: 22103673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
    Zatta AJ; Kin H; Lee G; Wang N; Jiang R; Lust R; Reeves JG; Mykytenko J; Guyton RA; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):315-24. PubMed ID: 16443207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic postconditioning reduces infarct size through the α1-adrenergic receptor pathway.
    Buchholz B; D Annunzio V; Giani JF; Siachoque N; Dominici FP; Turyn D; Perez V; Donato M; Gelpi RJ
    J Cardiovasc Pharmacol; 2014 Jun; 63(6):504-11. PubMed ID: 24406486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial infarction.
    Araszkiewicz A; Grygier M; Pyda M; Rajewska J; Lesiak M; Grajek S
    J Cardiol; 2015 Jun; 65(6):459-65. PubMed ID: 25828740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning.
    Guo HT; Zhang RH; Zhang Y; Zhang LJ; Li J; Shi QX; Wang YM; Fan R; Bi H; Yin W; Pei JM
    J Cardiovasc Pharmacol; 2011 Aug; 58(2):207-15. PubMed ID: 21654505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.
    Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ
    Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor binding following myocardial infarction in the rat.
    Sun Y; Weber KT
    Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits.
    Donato M; D'Annunzio V; Berg G; Gonzalez G; Schreier L; Morales C; Wikinski RL; Gelpi RJ
    J Cardiovasc Pharmacol; 2007 May; 49(5):287-92. PubMed ID: 17513947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
    Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
    Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
    Li C; Han R; Kang L; Wang J; Gao Y; Li Y; He J; Tian J
    Sci Rep; 2017 Jan; 7():40523. PubMed ID: 28091615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.